Brinton Pharma gets DCGI nod for Faviton 400 mg
It will be available across all COVID-19 treatment centres at Rs 79 per tab
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Jan Aushadhi stores selling branded generics instead of pure generics: Karnataka Pharmacists…
The association has also raised concerns about the sale of medicines in the absence of registered pharmacists which may lead to…
Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute…
Indicated for the treatment of CLI due to Buerger’s Disease and Atherosclerotic Peripheral Arterial Disease, it is the first…
J&J to buy Momenta in $6.5 bn deal
The acquisition will bolster J&J’s portfolio of drugs for autoimmune diseases
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib
The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)
How robots are lending a hand with healthcare, medical devices and pharma worldwide
From pharma and medical device production to medical and research laboratories, the latest robotics solutions can support the…
AstraZeneca gets DCGI nod to import and market Olaparib film coated tablets
It is additionally indicated as a monotherapy to treat adults with metastatic castration-resistant prostate cancer and homologous…
ZIM Labs in exclusive licensing agreement with Hypera Pharma for Vitamin D3 orally dispersible films
The product is intended for bone health in infants and the elderly
Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India
Dr Reddy’s AVIGAN comes in a pack of 122 tablets with a two-year shelf life
UK MHRA inspection of Strides facility at Puducherry concludes successfully
The company receives renewed GMP status for the facility from UK MHRA
AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical…
RIL buys majority stake in Netmeds
The Rs 620 crore deal gives RIL 60 per cent holding in equity capital of Vitalic and 100 per cent direct equity ownership of its…
Gujarat FDCA to suspend product licenses of over 70 hand sanitisers
In the last three months, it has raided the premises of five firms making hand sanitisers and seized over Rs 40 lakhs of material
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate
The Johnson & Johnson vaccine candidate is the fourth to be approved for human trials in Brazil
India in talks with developer of Russian COVID-19 vaccine: The Indian Express
Russian regulators recently approved the Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and…
Online pharmacies urge government to notify e-Pharmacy Draft Rules
The Indian e-pharmacy market has recorded approximately $700 million investments in during FY20
Fusion Health Care launches favipiravir for COVID-19 treatment
The drug to be marketed under brand name, XARAVIR
Biological E. acquires Akorn India
The timing of this acquisition is fortuitous as it will immediately allow us to expand our capacity to manufacture our…
Sanofi to acquire Principia Biopharma
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases